Hypochondriasis, somatoform disorders, and anxiety disorders: sociodemographic variables, general psychopathology, and naturalistic treatment effects.

Department of Psychology, University of Mainz, Mainz, Germany.
The Journal of nervous and mental disease (Impact Factor: 1.81). 05/2012; 200(5):406-12. DOI: 10.1097/NMD.0b013e31825322e5
Source: PubMed

ABSTRACT The question of whether hypochondriasis (HYP) should be considered a somatoform disorder (SFD) or classified as an anxiety disorder (ANX) has recently been raised. To empirically provide information on this issue, we compared patients with HYP (n = 65) with those with other SFDs (n = 94) and those with ANX (n = 224) regarding sociodemographic and biographical variables, general psychopathology, and naturalistic cognitive-behavioral therapy treatment effects. Compared with SFD, patients with HYP were younger and had fewer comorbid affective disorders and less impaired life domains, suggesting a closer connection between HYP and ANX. Regarding cognitive-behavioral therapy treatment effects, all diagnostic groups showed comparable significant improvement (d = 0.44-0.64). According to level of anxiety, the SFD sample had significantly lower pretreatment scores than did the ANX and the HYP samples. The results suggest that patients with HYP have an interim position between SFD and ANX, with slightly closer connections to ANX.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Distortions in interoceptive accuracy have been linked to somatoform disorders. In line with cognitive theories of symptom formation in somatoform disorders, decreases in interoceptive accuracy have recently been observed to co-occur with more severe symptom reports. The current study tested the hypothesis that experimentally increasing interoceptive accuracy should decrease symptom severity in somatoform disorders. Twenty-nine patients with somatoform disorders were instructed in a newly developed heartbeat perception training procedure. Heartbeat perception, as a proxy for interoceptive accuracy, was assessed with a mental tracking task. Although there were no significant differences between the training group and a waiting control group (n = 23) regarding increases in heartbeat perception, health anxiety served as a moderator and significant reductions in state symptom reports were observed after training. These findings suggest a relation between lower interoceptive accuracy and the perception of bodily symptoms in somatoform disorders.
    Biological Psychology 09/2014; 101:69-76. DOI:10.1016/j.biopsycho.2014.05.012 · 3.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In der 5. Auflage des Diagnostic and Statistical Manual of Mental Disorders (DSM-5) ist eine Revision der diagnostischen Klassifikation somatoformer Störungen erfolgt. Das Ziel des vorliegenden Beitrags besteht darin zu untersuchen, ob sich a) Patienten mit den DSM-IV-Diagnosen Somatisierungsstörung, Schmerzstörung und Hypochondrie sowie b) Patienten mit den DSM-5-ähnlichen Diagnosen ,,somatic symptom disorder“ (SSD) und ,,illness anxiety disorder“ hinsichtlich ihrer Krankheitsangst und ihrer Kognitionen bezüglich der Wahrnehmung und Interpretation somatischer Symptome unterscheiden.Es wurden Daten von 269 Patienten, die sich in stationärer psychosomatischer Behandlung in der Schön Klinik Bad Bramstedt befanden, analysiert. Die Diagnostik für somatoforme Störungen erfolgte anhand des Strukturierten Klinischen Interviews für DSM-IV (SKID).Patienten mit der DSM-IV-Diagnose Hypochondrie unterschieden sich hinsichtlich des Ausmaßes ihrer Krankheitsangst sowie der katastrophisierenden Bewertung von Körpersymptomen von Patienten mit anderen somatoformen Störungen. Patienten mit Illness anxiety disorder unterschieden sich im Ausmaß der katastrophisierenden Bewertung von Körpersymptomen, im Ausmaß vegetativer Missempfindungen, im Selbstkonzept körperlicher Schwäche und in der Intoleranz von körperlichen Beschwerden von Patienten mit SSD.Krankheitsängste und Katastrophisierung von Körperbeschwerden spielen bei Patienten mit somatoformen Störungen grundsätzlich eine Rolle. Auch bei Patienten mit SSD und somit im Vordergrund stehenden Körpersymptomen spielen krankheitsbezogene dysfunktionale Kognitionen eine Rolle. Im Hinblick auf eine psychotherapeutische Behandlung sollten Krankheitsangst und Befürchtungen bezüglich der eigenen Gesundheit bei allen Patienten mit somatoformen Störungen thematisiert werden.
    Psychotherapeut 11/2013; 58(6). DOI:10.1007/s00278-013-1019-z · 0.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The World Health Organization (WHO) is currently revisiting the ICD. In the 10th version of the ICD, approved in 1990, hypochondriacal symptoms are described in the context of both the primary condition hypochondriacal disorder and as secondary symptoms within a range of other mental disorders. Expansion of the research base since 1990 makes a critical evaluation and revision of both the definition and classification of hypochondriacal disorder timely. This article addresses the considerations reviewed by members of the WHO ICD-11 Working Group on the Classification of Obsessive-Compulsive and Related Disorders in their proposal for the description and classification of hypochondriasis. The proposed revision emphasizes the phenomenological overlap with both anxiety disorders (e.g., fear, hypervigilance to bodily symptoms, and avoidance) and obsessive-compulsive and related disorders (e.g., preoccupation and repetitive behaviors) and the distinction from the somatoform disorders (presence of somatic symptom is not a critical characteristic). This revision aims to improve clinical utility by enabling better recognition and treatment of patients with hypochondriasis within the broad range of global health care settings.
    Revista Brasileira de Psiquiatria 01/2014; 36 Suppl 1:21-7. DOI:10.1590/1516-4446-2013-1218 · 1.64 Impact Factor